KVUE Stock Price Today (April 2026) — Kenvue Inc. Analysis & Key Metrics 2026-04-02
Kenvue Inc. (KVUE) is trading at $17.47, up 0.52% today (as of April 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Consumer Defensive growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $19.83 (13.5% upside).
- Volatility remains elevated (12.18% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (3.20% YoY) alongside significant competitive pressures.
KVUE Stock Analysis: Key Metrics & Valuation (April 2026)
Concise, actionable data for investors
Kenvue Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $40.46B
P/E Ratio
Forward P/E: 14.16
Revenue Growth
Year over Year
Analyst Target
+13.5% upside potential
Key Investor Questions About KVUE
What investors need to know before buying
Based on current market data, KVUE presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 33.59)
- Fundamentals say: Caution warranted (high leverage concerns)
KVUE's growth trajectory depends on its ability to expand within the Household & Personal Products sector while managing margin pressures.
- Future growth will depend on performance in core Household & Personal Products operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for KVUE investors include debt exposure and competitive dynamics in the Household & Personal Products industry.
- $8.67B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Household & Personal Products.
52-Week Trading Range
Over the past year, KVUE stock traded between $14.02 and $25.17—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 12.18% annualized volatility and β=0.47, the stock exhibits low sensitivity to market moves—making KVUE suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings
Depending on who you ask, there is a chance we will get no interest rate cuts in 2026, or if we do, it’ll be just one. Inflation fueled by higher energy costs, tariffs, and a host of other factors could be the reason the Federal Reserve cites for not lowering rates until those rising costs ... Boomers and Retirees Are Sticking With 5 of the Highest-Yielding Dividend Kings
How Kenvue’s AAD 2026 Sun Care Science Push At Kenvue (KVUE) Has Changed Its Investment Story
At the 2026 American Academy of Dermatology Annual Meeting in Denver, Kenvue’s Neutrogena, Aveeno and Rogaine brands showcased new science-backed skincare and haircare products, 20 research abstracts, and educational initiatives for dermatology professionals, highlighting advances in hydration, acne care, healthy aging and sun protection. A particularly interesting angle for investors is Kenvue’s push to lead US sun care innovation by spotlighting bis-ethylhexyloxyphenol methoxyphenyl...
Do Not Build a Retirement Portfolio in 2026 Without at Least One of These 3 Dividend Kings
Dividend King stocks are turning into a necessity for all portfolios, even growth-focused ones. Stocks like PepsiCo (NASDAQ:PEP), Federal Realty Investment Trust (NYSE:FRT), and Kimberly-Clark (NASDAQ:KMB) are now a must-have, especially for retirement portfolios. Why? It is because most retirement investors have gone too deep into covered-call ETFs that track tech stocks and do not have enough ballast. ... Do Not Build a Retirement Portfolio in 2026 Without at Least One of These 3 Dividend King
Colgate's Pet Nutrition Strength: Can Hill's Sustain Momentum?
CL's Hill's Pet Nutrition outperforms a soft market as prescription diets, cat growth and science-led innovation drove share gains and sustained momentum.
This Healthcare Stock Barely Flinches During Market Sell-Offs
Shares of Johnson & Johnson have fallen by less than 2% over the past month, while the S&P 500 has fallen by more than 7%.
Beyond Meat Q4 Loss Wider Than Estimates, Revenues Decline Y/Y
BYND faces steep sales and margin pressure as weak demand and rising costs weigh on results, with cautious first-quarter 2026 revenue guidance ahead.
Here's Why Kenvue (KVUE) Could be Great Choice for a Bottom Fisher
Kenvue (KVUE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
PRPL Q4 Loss Narrower Than Estimates, Sales Rise on Wholesale Strength
Purple's Q4 loss narrows and sales rise 9.1% y/y as wholesale strength, cost cuts and Rejuvenate 2.0 momentum marked a turnaround in 2026.
Stock Market Crash Likely Won’t Hurt 5 Safe High-Yielding Dividend Kings
Companies that have raised dividends for shareholders for 50 years or more are the kinds of investments passive income investors need to own. Dependability is crucial for individuals seeking to increase their annual income through dividend stock investments. The Dividend Kings are the 57 companies that have raised their dividends for at least 50 years, ... Stock Market Crash Likely Won’t Hurt 5 Safe High-Yielding Dividend Kings
Assessing Johnson & Johnson (JNJ) Valuation After Recent Gains And Kenvue Spin Off
Recent Performance Snapshot Johnson & Johnson (JNJ) has drawn fresh attention after recent trading, with the stock closing at US$239.93. Short term moves include a 2.0% gain over the past day and 1.1% across the past week. See our latest analysis for Johnson & Johnson. While the 1 day and 7 day share price returns have been positive, the 30 day share price return of 2.4% contrasts with a stronger 90 day gain of 15.5% and a 1 year total shareholder return of 52.5%, which together indicate that...
Frequently Asked Questions
Common investor questions about Kenvue Inc.
Kenvue Inc. (KVUE) is currently trading at $17.47. The RSI (14-day) is at 33.6, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $19.83 implies 13.5% upside from current levels. Volatility is low at 12.2% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Kenvue Inc. (KVUE): The trailing P/E ratio is 22.55, which is in line with broader market averages. The forward P/E is 14.16, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.48, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.05. Price-to-Sales is 2.17. Valuation should be compared to Household & Personal Products industry peers for context, as different sectors trade at different multiples.
Based on 12 analysts covering KVUE, the consensus price target is $19.83. This represents a 13.5% upside from the current price of $17.47. The range spans from a low target of $18.00 to a high target of $23.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Kenvue Inc. (KVUE) pays a dividend with a current yield of approximately 4.79%. The annualized dividend rate is $0.82 per share. The payout ratio is 108.5%, which exceeds 100%—this means the company is paying out more than it earns, which may not be sustainable long-term. The most recent ex-dividend date was 2026-02-11.
Key risks for Kenvue Inc. (KVUE) investors include: 1. Unsustainable dividend payout ratio (109%) could lead to a dividend cut. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Household & Personal Products sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Kenvue Inc.'s (KVUE) current debt and financial health profile: Total debt stands at $8.67B. The debt-to-equity ratio is 80.58, which is elevated and warrants monitoring, especially in a rising interest rate environment. The current ratio is 0.96, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.58. The company holds $1.06B in cash and equivalents. Free cash flow is positive at $1.81B, providing a cushion for debt servicing and shareholder returns.